NCT02216877View on ClinicalTrials.gov

Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Chronic Kidney DiseaseHypomagnesemia
Interventions
DRUG

Mablet 360 mg

DRUG

Placebo

Trial Locations (1)

Unknown

Department of Medicine, Division of Nephrology, Roskilde County Hospital, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT02216877 - Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter